Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis

被引:1
作者
Takeyama, M [1 ]
Nagai, S [1 ]
Mori, K [1 ]
Ikawa, K [1 ]
Satake, N [1 ]
Izumi, T [1 ]
机构
[1] KYOTO UNIV, CHEST DIS RES INST, DEPT MED 2, KYOTO, JAPAN
关键词
bronchoalveolar lavage fluid; smoking; pulmonary function; substance P; idiopathic pulmonary fibrosis; sarcoidosis;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
In order to find out whether substance P (SP) participates in the inflammatory and fibrotic processes of interstitial lung diseases or not, SP-like immunoreactive substance (SP-IS) concentrations in bronchoalveolar lavage (BAL) fluids from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis were measured using enzyme immunoassay (EIA). The mean SP-IS concentrations in BAL fluids from healthy nonsmokers and healthy smokers were 0.87 +/- 0.19 and 0.98 +/- 0.23 pg/ml, respectively. The mean SP-IS concentration in BAL fluids from patients with IPF was 1.15 +/- 0.39 pg/ml. The value of patients with IPF was significantly higher than that of healthy nonsmokers (p<0.01). The mean SP-IS concentrations in BAL fluids from pulmonary sarcoidosis patients in stage I, stage II and stage III were 0.91 +/- 0.19, 0.96 +/- 0.35 and 1.00 +/- 0.29 pg/ml, respectively. No correlation was found between SP-IS concentration and pulmonary functions in IPF and sarcoidosis patients. The present results indicate that SP may be involved in the inflammatory process in IPF.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 34 条
  • [1] INCREASED NUMBERS OF LYMPHOCYTE-T WITH GAMMA-DELTA-POSITIVE ANTIGEN RECEPTORS IN A SUBGROUP OF INDIVIDUALS WITH PULMONARY SARCOIDOSIS
    BALBI, B
    MOLLER, DR
    KIRBY, M
    HOLROYD, KJ
    CRYSTAL, RG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) : 1353 - 1361
  • [2] NEUROPEPTIDES IN HUMAN AIRWAYS - FUNCTION AND CLINICAL IMPLICATIONS
    BARNES, PJ
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (06): : S77 - S83
  • [3] NEUROPEPTIDES IN THE RESPIRATORY-TRACT .1.
    BARNES, PJ
    BARANIUK, JN
    BELVISI, MG
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05): : 1187 - 1198
  • [4] NEUROPEPTIDES AND ASTHMA
    BARNES, PJ
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (03): : S28 - S32
  • [5] BARNES PJ, 1986, LANCET, V1, P242
  • [6] SUBSTANCE-P AND VASOACTIVE-INTESTINAL-PEPTIDE IN NASAL SECRETIONS AND PLASMA FROM PATIENTS WITH NASAL ALLERGY
    CHAEN, T
    WATANABE, N
    MORI, K
    MOGI, G
    TAKEYAMA, M
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1993, 102 (01) : 16 - 21
  • [7] CUELLO AC, 1982, CIBA F SYMP, V91, P55
  • [8] BRONCHOALVEOLAR LAVAGE - ROLE IN THE PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT OF INTERSTITIAL LUNG-DISEASE
    DANIELE, RP
    ELIAS, JA
    EPSTEIN, PE
    ROSSMAN, MD
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 102 (01) : 93 - 108
  • [9] EMURA M, 1990, CLIN EXP IMMUNOL, V82, P133
  • [10] MECHANISMS OF NEUTROPHIL ACCUMULATION IN THE LUNGS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    HUNNINGHAKE, GW
    GADEK, JE
    LAWLEY, TJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (01) : 259 - 269